Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26

Semi stocks soaring, as Intel and memory names jump double digits. How much more this trade can climb, and how our traders are positioning in the chip rip. Plus, Meta’s copyright complications, Coinbase cuts heads as AI shakes up the workforce, and the CEO of biopharma company Protagonist on its recent drug approval and the stock’s big run up over the past year. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

You can listen to Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26 online on Radio and Podcast. Open the player on this page to stream the available audio.

Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26 is an episode from CNBC's "Fast Money" by CNBC.

This episode is 00:43:28 long.

This episode was published on May 5, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from CNBC's "Fast Money" when more episodes are available from the podcast feed.